search
Back to results

One Stage vs. Two Stage Gubernaculum Sparing Laparoscopic Orchidopexy (GSLO) (GSLO)

Primary Purpose

Cryptorchidism

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Two-Stage GSLO Technique
One-Stage GSLO Technique
Sponsored by
McMaster University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cryptorchidism

Eligibility Criteria

1 Year - 5 Years (Child)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • boys 1-5 years of age at presentation to Pediatric Urology Clinics
  • patients diagnosed with intraabdominal UDT
  • patients who require one- or two-stage repair performed by fellowship-trained Pediatric Urologists

Exclusion Criteria:

  • patients who have undergone previous laparoscopic orchidopexy
  • patients with palpable testes
  • patients requiring orchiectomy

Sites / Locations

  • McMaster Children's HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Intervention Group: Two-Stage GSLO Technique

Control Group: One-Stage GSLO Technique

Arm Description

Gubernaculum-sparing laparoscopic orchidopexy will be done in two stages

Gubernaculum-sparing laparoscopic orchidopexy will be done in a single stage

Outcomes

Primary Outcome Measures

Rate of Postoperative Testicular Atrophy at 3 Months
How many children have been diagnosed with testicular atrophy 3 months after the surgery has been performed.
Rate of Postoperative Testicular Atrophy at 12 Months
How many children have been diagnosed with testicular atrophy 12 months after the surgery has been performed.
Recruitment Rate
Will be calculated as the percentage of eligible participants enrolled
Frequency of protocol violations
Will be calculated as the number of protocol violations that occurred during the pilot phase of this trial.
Frequency of adverse events
Will be calculated as the number of documented adverse events during the pilot phase of this trial.

Secondary Outcome Measures

Full Information

First Posted
October 7, 2016
Last Updated
October 18, 2023
Sponsor
McMaster University
Collaborators
McMaster Surgical Associates
search

1. Study Identification

Unique Protocol Identification Number
NCT02936024
Brief Title
One Stage vs. Two Stage Gubernaculum Sparing Laparoscopic Orchidopexy (GSLO)
Acronym
GSLO
Official Title
One Stage vs. Two Stage Gubernaculum Sparing Laparoscopic Orchidopexy: A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 11, 2017 (Actual)
Primary Completion Date
September 2025 (Anticipated)
Study Completion Date
September 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
McMaster University
Collaborators
McMaster Surgical Associates

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Undescended Testis (UDT) is the most common congenital anomaly of the genitalia in boys and it is commonly managed by surgical intervention. Patients with intra-abdominal or non palpable testis, specifically, are often managed using a laparoscopic assisted orchidopexy, a common surgical technique to bring undescended testes down into the scrotum. Evidence in the medical literature to support the superiority of either one stage or two stage gubernaculum sparing laparoscopic orchidopexy (GSLO) is lacking. Due to this reason, this study focuses on the effects of one stage versus two stage GSLO on a patient important outcome: testicular atrophy.
Detailed Description
The principal research question to be addressed is: what is the feasibility of a randomized controlled trial to assess whether in boys, 1-5 years of age, diagnosed with intraabdominal UDT, two-stage GSLO results in fewer postoperative testicular atrophies when compared to single-stage GSLO? The results of this study will be used to assess the feasibility of a randomized controlled trial on this topic. If our protocol does not require significant modifications, then participants assessed in this pilot trial will be included as participants in the definitive multicenter trial. To the best of our knowledge, the full-scale trial will be the first prospective, multicenter, randomized controlled trial to study the success rates of single-stage and two-stage GSLO. The results of the definitive multicenter trial will inform guidelines both locally and nationally, regarding the efficacy of staged techniques for orchidopexy. The results of this study will also inform and improve current care for children with IAT, as atrophy rates can be as high as 33% using the traditional laparoscopic approach. Furthermore, if it is shown that a single stage approach is more efficacious than a two-stage approach, it will limit unnecessary exposure of young children to general anesthetic, which may be associated with an increased risk for learning disability or behavioral problems The control group will receive single-stage GSLO procedure, while the intervention group will receive a two-stage GSLO technique. The first stage of the two-stage technique involves the ligation of testicular vessels laparoscopically, or transection of these vessels using cautery. Approximately 3-6 months following the completion of the first stage, the patient is seen again and the second stage of the procedure is performed. Access is obtained with a Hasson technique through an umbilical incision. Dissection begins laterally and proceeds along the superior margin of the internal inguinal ring (IIR), extending medially beyond the obliterated umbilical artery, while preserving a wide strip of peritoneum between the testis and the gubernaculum. Further dissection is then performed proximally, near the bifurcation of the iliac vessels, which allows free mobilization of this peritoneal triangle containing collateral blood supply to the testis. Next, a laparoscopic grasper is advanced through the IIR alongside the gubernaculum, and into the most dependent aspect of the scrotum. The distal gubernacular attachments and preserved cremasteric vessels, along with the testis, are pulled through the IIR with the assistance of a laparoscopic grasper, following the normal testicular descent route into the ipsilateral scrotum. Upon completion of dissection and descent, the testis is fixed to the scrotum in a sub-dartos pouch with a single 4-0 polydioxanone (PDS) stitch. If the patient is randomized to receive single-stage GSLO procedure, it is important to note that both the ligation of testicular vessels and the mobilization of the testis occur during the same operation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cryptorchidism

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Intervention Group: Two-Stage GSLO Technique
Arm Type
Experimental
Arm Description
Gubernaculum-sparing laparoscopic orchidopexy will be done in two stages
Arm Title
Control Group: One-Stage GSLO Technique
Arm Type
Other
Arm Description
Gubernaculum-sparing laparoscopic orchidopexy will be done in a single stage
Intervention Type
Procedure
Intervention Name(s)
Two-Stage GSLO Technique
Intervention Description
The patient will initially receive the first stage of the two-stage technique which involves the ligation of testicular vessels laparoscopically, or transection of these vessels using cautery. After the first stage is complete, the patient will be seen approximately 3-6 months later for the second stage. The second stage of the procedure involves free mobilization of the testis and placement/fixation of the testicle in the scrotum.
Intervention Type
Procedure
Intervention Name(s)
One-Stage GSLO Technique
Intervention Description
The patient will receive only one surgical procedure during which ligation of testicular vessels is performed, as well as mobilization of the testis and placement/fixation of the testicle in the scrotum.
Primary Outcome Measure Information:
Title
Rate of Postoperative Testicular Atrophy at 3 Months
Description
How many children have been diagnosed with testicular atrophy 3 months after the surgery has been performed.
Time Frame
3 months postoperatively
Title
Rate of Postoperative Testicular Atrophy at 12 Months
Description
How many children have been diagnosed with testicular atrophy 12 months after the surgery has been performed.
Time Frame
12 months postoperatively
Title
Recruitment Rate
Description
Will be calculated as the percentage of eligible participants enrolled
Time Frame
Through study completion, an average of 2 years
Title
Frequency of protocol violations
Description
Will be calculated as the number of protocol violations that occurred during the pilot phase of this trial.
Time Frame
Through study completion, an average of 2 years
Title
Frequency of adverse events
Description
Will be calculated as the number of documented adverse events during the pilot phase of this trial.
Time Frame
Through study completion, an average of 2 years

10. Eligibility

Sex
Male
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: boys 1-5 years of age at presentation to Pediatric Urology Clinics patients diagnosed with intraabdominal UDT patients who require one- or two-stage repair performed by fellowship-trained Pediatric Urologists Exclusion Criteria: patients who have undergone previous laparoscopic orchidopexy patients with palpable testes patients requiring orchiectomy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Luis H Braga, M.D.
Phone
905-521-2100
Ext
73777
Email
braga@mcmaster.ca
First Name & Middle Initial & Last Name or Official Title & Degree
Melissa McGrath
Phone
905-521-2100
Ext
73654
Email
mcgram2@mcmaster.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Luis H Braga, M.D.
Organizational Affiliation
McMaster University
Official's Role
Principal Investigator
Facility Information:
Facility Name
McMaster Children's Hospital
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8N 3Z5
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Luis Braga, MD
Phone
905-521-2100
Ext
73777
Email
braga@mcmaster.ca

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

One Stage vs. Two Stage Gubernaculum Sparing Laparoscopic Orchidopexy (GSLO)

We'll reach out to this number within 24 hrs